No internet connection — showing the saved version of the page.

Progyny Inc

USUSD
← to the screener

Progyny Inc (US:PGNY) — Misc Health and Biotechnology Services. Number of exchanges where the company shares trade: 1. On this page — price and chart, dividends, top holders and share count history.

About the company

Website
progyny.com
Investor relations
investors.progyny.com/
Sector
Health Care · Misc Health and Biotechnology Services
Headquarters
NEW YORK, United States
Management
Peter Anevski
Employees
835
IPO
2019-10-25
Shares outstanding
73.65 M as of 2026-10-31
DateSharesChange
31.10.202673.65 M−4.0%buyback
31.07.202676.73 M
Share count from the company reports. A split is detected by a jump in the count by a whole number of times.
Free float
67.41 M
Market cap
2.57 B USD
Insiders
2.04%
Institutions
112.06%
Industry (SIC)
Services-Misc Health & Allied Services, NEC
P/E
32.5
EPS
1.09 USD
|
6.40
Graham number
11.29 USD price 214% above
ROE
19.1%
FCF
180 M USD
Debt
?
Earnings and FCF — for the 12 months to 30.09.2026 (the company's latest report).
Net income
91.0 M USD 12 mo.
For the 12 months to 30.09.2026 (4 quarters)
Revenue1.34 B USD
− Expenses1.21 B USD
Gross profit333 M USD
Net income91.0 M USD
History by quarter
RevenueExpenses
31.12.2023: Revenue 270 M · Expenses 256 M · Operating profit 13.8 M · Net income 13.5 M31.03.2024: Revenue 278 M · Expenses 260 M · Operating profit 18.5 M · Net income 16.9 M30.06.2024: Revenue 304 M · Expenses 283 M · Operating profit 20.7 M · Net income 16.5 M30.09.2024: Revenue 287 M · Expenses 274 M · Operating profit 12.5 M · Net income 10.4 M31.12.2024: Revenue 298 M · Expenses 283 M · Operating profit 15.8 M · Net income 10.5 M31.03.2025: Revenue 324 M · Expenses 300 M · Operating profit 24.2 M · Net income 15.1 M30.06.2025: Revenue 333 M · Expenses 309 M · Operating profit 24.4 M · Net income 17.1 M30.09.2025: Revenue 313 M · Expenses 292 M · Operating profit 21.5 M · Net income 13.9 M31.12.2025: Revenue 318 M · Expenses 303 M · Operating profit 15.2 M · Net income 12.5 M31.03.2026: Revenue 329 M · Expenses 293 M · Operating profit 35.4 M · Net income 24.2 M30.06.2026: Revenue 351 M · Expenses 311 M · Operating profit 40.0 M · Net income 28.1 M30.09.2026: Revenue 341 M · Expenses 306 M · Operating profit 35.2 M · Net income 26.3 M
12.202309.2026
Green above orange is profit (revenue − expenses); red below zero is a loss.
NAV
5.54 USD · P/NAV 6.40
Balance sheet date30.09.2026
Assets676 M USD
− Liabilities262 M USD
= NAV (equity of the company's shareholders)414 M USD
− Goodwill19.8 M USD
− Intangible assets5.53 M USD
= Tangible NAV389 M USD
Shares74 723 072
NAV per share5.54 USD
Tangible NAV per share5.20 USD
Share price (PGNY)35.4500 USD
P/NAV6.40
NAV history
Balance sheet dateNAVNAV per share
30.09.2026414 M USD5.54 USD
30.06.2026453 M USD5.86 USD
31.03.2026439 M USD5.61 USD
31.12.2025516 M USD6.19 USD
30.09.2025560 M USD6.50 USD
30.06.2025515 M USD5.99 USD
31.03.2025467 M USD5.45 USD
31.12.2024422 M USD4.95 USD
Description

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

advertisement

Exchanges and tickers

ExchangeTickerCurrencyPriceType
US USA StocksPGNYUSD35.45 -1.96%common stock

Price

US:PGNY · USD
Hover / tap a day — open, close, high and low prices

News this week

Press releases from the company's investor website, updated daily. Links lead to the company's website. Headlines are in the original language, as on the company website.

Top holders

HolderStakeSharesReport date
Blackrock Inc.15.12%11.6 M2026-06-30
FMR, LLC9.13%7 M2026-06-30
Vanguard Portfolio Manag…6.54%5.02 M2026-06-30
iShares Trust-iShares Co…5.95%4.57 M2026-09-30
Vanguard Capital Managem…4.18%3.21 M2026-06-30
State Street Corporation3.94%3.02 M2026-06-30
Ameriprise Financial, In…3.6%2.76 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.92%2.24 M2026-06-30
Fidelity Securities Fund…2.64%2.03 M2026-08-31
Geode Capital Management…2.57%1.97 M2026-06-30
Touchstone Strategic TRT…2.53%1.94 M2026-06-30
American Century ETF Tru…2.51%1.93 M2026-09-30
iShares Trust-iShares Ru…2.48%1.9 M2026-09-30
Citadel Advisors Llc2.33%1.79 M2026-06-30
Dimensional Fund Advisor…2.31%1.77 M2026-09-30
Fort Washington Investme…2.13%1.64 M2026-09-30
VANGUARD INDEX FUNDS-Van…2.11%1.62 M2026-06-30
Fidelity Rutland Square…1.62%1.25 M2026-09-30
Fidelity Securities Fund…1.35%1.03 M2026-08-31
VANGUARD INDEX FUNDS-Van…1.21%927 4162026-06-30
ANEVSKI PETER (Chief Exe…≈1.06%816 8342026-03-02
PAYSON NORMAN (Director)≈0.61%466 2052026-05-21
SCHLANGER DAVID J (Offic…≈0.31%240 6332025-11-10
SWARTZ ALLISON (General…≈0.11%83 9762026-11-02
LIVINGSTON MARK S (Chief…≈0.1%74 6882026-06-04
CUMMINGS MELISSA B (Chie…≈0.09%69 9342026-07-14
CLAPP GEOFFREY (Officer)≈0.08%60 6472026-06-02
PARK JEFFREY G (Director…≈0.05%39 9812026-05-21
HOLSTEIN ROGER C (Direct…≈0.04%28 7292026-05-21
DEAN LLOYD H (Director)≈0.03%26 5192026-05-21